Trying to Keep Up
RWE Meets Review Reality: Data, Doubts, and the FDA | ft. Joshua Levin | 5/7/26
1:00:10
AI warning letters. Cybersecurity deficiencies. Real-world evidence debates. FDA’s ELSA rollout. This week’s TTKU covered a lot.
Allison Komiyama and Michael Nilo are joined by former FDA reviewer and current precision medicine regulatory expert Josh Levin to unpack the latest developments across medical devices, diagnostics, AI, and regulatory policy.
The team dives into FDA’s newest De Novo…